SOURCE: Research and Markets

Research and Markets

March 16, 2016 08:26 ET

Global Precision Medicine Market (2015-2022) -- Key Players are IBM, Intel, GE Healthcare, Novartis & Medtronic

DUBLIN, IRELAND--(Marketwired - March 16, 2016) -  Research and Markets has announced the addition of the "Global Precision Medicine Market -- Estimates and Forecasts Through (2015-2022)" report to their offering.

Most of the advancements in this market are being driven by advancements in precision oncology techniques. As a result a patient diagnosed with cancer in 2004 would have had only a 10% chance of obtaining the right treatment for the disease as compared to a 70-80% chance of getting the right treatment today.

With these crucial segments setting pace, the global precision market is set to be valued at close to $88 billion by 2022 at an estimated CAGR of 12.60% from 2015 to 2022 with North America and Europe setting pace for the Rest of the World, according to Global Precision Medicine Market -- Estimation & Forecast (2015-2022) report.

The growth in the precision medicine market is propelled by an increasing demand for personalized treatment, technological innovation and advancement (including Biomarker-based tests/kits, next gene sequencing, and precise imaging), government support and regulations.

The main aim of these regulations is to make precision medicines more adaptable and focused towards genetic diseases related to oncology, skin, respiratory, CNS, CVD, and infectious diseases among others. The patients are benefited indirectly by these regulations as they save time and cut down costs as the patients get the required treatment for the specific disease.

Key Topics Covered:

1 Report Scope

2 Executive Summary

3 Market Overview

4 Market Dynamics

5 Industry Dynamics

6 Global Precision Medicine Market By Ecosystem Players

7 Global Precision Medicine Market By Sub-Markets

8 Global Precision Medicine Market By Therapeutics

9 Global Precision Medicine Market By Geography

10 Company Profiles

Companies Profiled:

  • AB-Biotics Sa
  • Abbott Laboratories
  • Almac Group, Ltd.
  • Asuragen, Inc.
  • Biobase Gmbh (Subsidiary)
  • Biomérieux Sa
  • Caris Life Sciences
  • Cepheid Inc.
  • Cetics Healthcare Technologies Gmbh
  • GE Healthcare
  • Glaxosmithkline Plc (Gsk)
  • Healthcore, Inc.
  • IBM
  • Intel Corporation
  • Intomics A/S
  • Johnson & Johnson
  • Laboratory Corporation Of America Holdings
  • Medtronic
  • Novartis
  • Qiagen
  • Quest Diagnostics Inc
  • Randox Laboratories Ltd.
  • Roche Holding Ag-Br
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

For more information visit http://www.researchandmarkets.com/research/43pvkk/global_precision.

Sector: Pharmaceuticals

Image Available: http://www.marketwire.com/library/MwGo/2016/3/16/11G087788/Images/global_precision_medicine_market_estimates_and-160c671c132fbdb2bf003af89192039a.jpg

Contact Information

  • Research and Markets
    Laura Wood
    Senior Manager
    press@researchandmarkets.com

    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716